82 related articles for article (PubMed ID: 6326949)
1. Pharmacological study on the mixed CCK8/DA meso-nucleus accumbens pathway: evidence for the existence of storage sites containing the two transmitters.
Studler JM; Reibaud M; Tramu G; Blanc G; Glowinski J; Tassin JP
Brain Res; 1984 Apr; 298(1):91-7. PubMed ID: 6326949
[TBL] [Abstract][Full Text] [Related]
2. Distinct properties of cholecystokinin-8 and mixed dopamine-cholecystokinin-8 neurons innervating the nucleus accumbens.
Studler JM; Reibaud M; Tramu G; Blanc G; Glowinski J; Tassin JP
Ann N Y Acad Sci; 1985; 448():306-14. PubMed ID: 3861123
[No Abstract] [Full Text] [Related]
3. The importance of dopaminergic neurotransmission in the hypermotility response produced by the administration of N-methyl-D-aspartic acid into the nucleus accumbens.
Boldry RC; Uretsky NJ
Neuropharmacology; 1988 Jun; 27(6):569-77. PubMed ID: 2901677
[TBL] [Abstract][Full Text] [Related]
4. Opposite effects of sulfated cholecystokinin on DA-sensitive adenylate cyclase in two areas of the rat nucleus accumbens.
Studler JM; Reibaud M; Herve D; Blanc G; Glowinski J; Tassin JP
Eur J Pharmacol; 1986 Jul; 126(1-2):125-8. PubMed ID: 3758156
[TBL] [Abstract][Full Text] [Related]
5. In vivo electrochemical analysis of cholecystokinin-induced inhibition of dopamine release in the nucleus accumbens.
Lane RF; Blaha CD; Phillips AG
Brain Res; 1986 Nov; 397(1):200-4. PubMed ID: 3801862
[TBL] [Abstract][Full Text] [Related]
6. D1 dopamine receptor stimulation enables the postsynaptic, but not autoreceptor, effects of D2 dopamine agonists in nigrostriatal and mesoaccumbens dopamine systems.
Wachtel SR; Hu XT; Galloway MP; White FJ
Synapse; 1989; 4(4):327-46. PubMed ID: 2532422
[TBL] [Abstract][Full Text] [Related]
7. Reversal by cholecystokinin of apomorphine-induced inhibition of dopamine release in the nucleus accumbens of the rat.
Blaha CD; Phillips AG; Lane RF
Regul Pept; 1987 Jun; 17(6):301-10. PubMed ID: 3602473
[TBL] [Abstract][Full Text] [Related]
8. Expression of neuropeptide Y immunoreactivity in the rat nucleus accumbens is under the influence of the dopaminergic mesencephalic pathway.
Salin P; Kerkerian L; Nieoullon A
Exp Brain Res; 1990; 81(2):363-71. PubMed ID: 1975787
[TBL] [Abstract][Full Text] [Related]
9. Dopamine and neurotensin storage in colocalized and noncolocalized neuronal populations.
Bean AJ; Adrian TE; Modlin IM; Roth RH
J Pharmacol Exp Ther; 1989 Jun; 249(3):681-7. PubMed ID: 2732943
[TBL] [Abstract][Full Text] [Related]
10. Cholecystokinin-induced inhibition of dopamine neurotransmission: comparison with chronic haloperidol treatment.
Lane RF; Blaha CD; Phillips AG
Prog Neuropsychopharmacol Biol Psychiatry; 1987; 11(2-3):291-9. PubMed ID: 2819952
[TBL] [Abstract][Full Text] [Related]
11. Locomotor hypokinesia in the reserpine-treated rat: drug effects from the corpus striatum and nucleus accumbens.
Johnels B
Pharmacol Biochem Behav; 1982 Aug; 17(2):283-9. PubMed ID: 7134238
[TBL] [Abstract][Full Text] [Related]
12. Effects of locally applied dopamine to the nucleus accumbens on the motor activity of normal rats and following alpha-methyltyrosine or reserpine.
Wachtel H; Ahlenius S; Andén NE
Psychopharmacology (Berl); 1979 Jun; 63(3):203-6. PubMed ID: 113804
[TBL] [Abstract][Full Text] [Related]
13. Neurochemical asymmetries in the albino rat's cortex, striatum, and nucleus accumbens.
Rosen GD; Finklestein S; Stoll AL; Yutzey DA; Denenberg VH
Life Sci; 1984 Mar; 34(12):1143-8. PubMed ID: 6200745
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological characterization of dopamine systems in the nucleus accumbens core and shell.
Deutch AY; Cameron DS
Neuroscience; 1992; 46(1):49-56. PubMed ID: 1350665
[TBL] [Abstract][Full Text] [Related]
15. Reserpine-induced rigidity in rats: drug effects on muscle tone from corpus striatum and nucleus accumbens.
Johnels B
Pharmacol Biochem Behav; 1983 Sep; 19(3):463-70. PubMed ID: 6605540
[TBL] [Abstract][Full Text] [Related]
16. Halothane enhances dopamine metabolism at presynaptic sites in a calcium-independent manner in rat striatum.
Adachi YU; Satomoto M; Higuchi H; Watanabe K; Yamada S; Kazama T
Br J Anaesth; 2005 Oct; 95(4):485-94. PubMed ID: 16113039
[TBL] [Abstract][Full Text] [Related]
17. The effects of cholecystokinin on the in vivo release of newly synthesized [3H]dopamine from the nucleus accumbens of the rat.
Voigt MM; Wang RY; Westfall TC
J Neurosci; 1985 Oct; 5(10):2744-9. PubMed ID: 4045551
[TBL] [Abstract][Full Text] [Related]
18. Effects of acute and chronic clozapine and haloperidol on in vitro release of acetylcholine and dopamine from striatum and nucleus accumbens.
Compton DR; Johnson KM
J Pharmacol Exp Ther; 1989 Feb; 248(2):521-30. PubMed ID: 2918468
[TBL] [Abstract][Full Text] [Related]
19. Direct observation of dopamine compartmentation in striatal nerve terminal by 'in vivo' measurement of the specific activity of released dopamine.
Leviel V; Gobert A; Guibert B
Brain Res; 1989 Oct; 499(2):205-13. PubMed ID: 2804675
[TBL] [Abstract][Full Text] [Related]
20. Stimulated limbic and striatal dopamine release measured by fast cyclic voltammetry: anatomical, electrochemical and pharmacological characterisation.
Stamford JA; Kruk ZL; Millar J
Brain Res; 1988 Jun; 454(1-2):282-8. PubMed ID: 3261616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
